XTL Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 05/13/2025 | 198.89 K | $238.00 K | 0.00% | 0.04% |
| CITADEL ADVISORS LLC | 05/15/2025 | 25.21 K | $31.26 K | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 13.25 K | $15.84 K | -27.79% | 0.00% |
| RHUMBLINE ADVISERS | 05/29/2025 | 10.95 K | $13.58 K | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XTL Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of XTL Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 198,888
CITADEL ADVISORS LLC: 25,211
MORGAN STANLEY: 13,251
RHUMBLINE ADVISERS: 10,954
Noked Capital LTD: 198,888
0.05% of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 447.19 K shares in the last 24 months. This purchase volume represents approximately $603.71 K in transactions.